Related Experiment Video

Updated: Aug 7, 2025

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification
07:23

Culture of Murine Embryonic Metatarsals: A Physiological Model of Endochondral Ossification

Published on: December 3, 2016

12.0K

SP7: from Bone Development to Skeletal Disease

Jialiang S Wang1, Nicha Tokavanich2,3, Marc N Wein2,4,5

  • 1Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. jwang101@mgh.harvard.edu.

Current Osteoporosis Reports
|March 7, 2023
PubMed
Abstract

Insights

The transcription factor SP7 is crucial for bone health and development. Mutations in SP7 lead to skeletal diseases, but SP7 and its networks offer promising therapeutic targets for bone disorders.

Area of Science:

  • Molecular Biology
  • Genetics
  • Bone Biology

Background:

  • The transcription factor SP7 plays vital roles in bone formation and remodeling.
  • SP7 is essential for normal bone development and overall skeletal health.
  • SP7 dysfunction is linked to various skeletal diseases, including osteoporosis and osteogenesis imperfecta.

Purpose of the Study:

  • To review the diverse functions of SP7 in bone metabolism.
  • To examine the link between SP7 mutations and human skeletal diseases.
  • To highlight SP7-targeting therapeutic strategies for bone disorders.

Main Methods:

  • Literature review of studies on SP7 function and skeletal disease.
  • Analysis of recent advances in genomics (whole genome/exome sequencing, GWAS) and multi-omics.
  • Inclusion of insights from CRISPR-mediated gene editing techniques.

Main Results:

  • SP7 exhibits cell-type and stage-specific roles in bone regulation.
  • SP7 mutations are causally linked to both common and rare skeletal diseases.
  • SP7-controlled pathways, target genes, and epigenetic modifications are identified as therapeutic targets.

Conclusions:

  • SP7 is a key regulator of bone development, critical for skeletal health.
  • Understanding SP7's regulatory network is crucial for diagnosing and treating skeletal diseases.
  • Targeting SP7 and its associated gene networks presents a promising therapeutic avenue for bone disorders.
Keywords:
Bone developmentSP7Skeletal diseaseTherapeutic approaches

More Related Videos

Culturing and Measuring Fetal and Newborn Murine Long Bones06:58

Culturing and Measuring Fetal and Newborn Murine Long Bones

Published on: April 26, 2019

8.3K
Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation07:17

Murine Hind Limb Long Bone Dissection and Bone Marrow Isolation

Published on: April 14, 2016

84.2K

Related Concept Videos

Bone Formation by Endochondral Ossification01:24

Bone Formation by Endochondral Ossification

Bone formation, or ossification, begins around the sixth to seventh week of embryonic development. Most bones develop from a cartilaginous template through the process of endochondral ossification. Cartilage formation begins when clusters of mesenchymal cells differentiate into chondrocytes. These chondrocytes proliferate rapidly and secrete an extracellular matrix that becomes encased in a membrane called the perichondrium. The resulting cartilage model provides a template that resembles the...
4.9K
Bone Formation by Intramembranous Ossification01:29

Bone Formation by Intramembranous Ossification

Intramembranous ossification is one of the two processes involved in the development of bones within an embryo. The flat bones of the face, most of the cranial bones, and the clavicles are formed via this process. During intramembranous ossification, the bones develop directly from sheets of undifferentiated mesenchymal connective tissue.
The process begins when mesenchymal cells in the embryonic skeleton gather together and differentiate into osteogenic cells, which then develop into ...
6.6K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Changes in the Appendicular Skeleton with Age01:09

Changes in the Appendicular Skeleton with Age

The upper and lower limb initially develops as a small bulge called a limb bud, which appears on the lateral side of the early embryo. The upper limb bud appears near the end of the fourth week of development, with the lower limb bud appearing shortly after.
Initially, the limb buds consist of a core of mesenchyme covered by a layer of ectoderm. The ectoderm at the end of the limb bud thickens to form a narrow crest called the apical ectodermal ridge. This ridge stimulates the underlying...
2.1K
Bone Remodeling01:40

Bone Remodeling

Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K
The Functions of the Skeletal System01:22

The Functions of the Skeletal System

The most apparent functions of the skeletal system are support, protection, and movement. However, bone tissue also performs several other critical metabolic functions. For one, the bone matrix acts as a reservoir for a number of minerals important to the functioning of the body, especially calcium and phosphorus. These minerals, present in the bone tissue, can be released back into the bloodstream when required. Calcium ions, for example, are essential for muscle contractions and controlling...
4.0K